Minister of Health’s Decision that JAMP is not a “Second Person” Was Reasonable
In its new drug submission for SIMLANDI, a biosimilar containing adalimumab, JAMP Pharma Corporation (“JAMP”) sought approval for three specific presentations: (i) 40 mg/0.4 mL pre-filled syringe; (ii) 40 mg/0.4 mL auto-injector pen; and (iii) 80 mg/0.8 mL pre-filled syringe.
Given that AbbVie did not market the equivalent presentations of HUMIRA (adalimumab) in Canada, in a comprehensive and detailed decision, the Minister of Health (the “Minister”) determined that JAMP was not a “second person” for purposes of subsection 5(1) of the Patented Medicines (Notice of Compliance) Regulations (the “PM(NOC) Regulations”) and was thus not required to address patents listed on the patent register by AbbVie before being issued a Notice of Compliance (“NOC”).
Subsequently, the Minister issued an NOC to JAMP for its three presentations of SIMLANDI.
In AbbVie Corporation et al. v. The Minister of Health and JAMP Pharma Corporation, 2022 FC 1209, Justice Fothergill of the Federal Court dismissed AbbVie’s applications to judicially review the Minister’s decisions, on the basis that the Minister’s decisions were reasonable.
Justice Fothergill observed that the “PM(NOC) Regulations are closely connected with the Minister’s functions, and the Minister has great expertise in their application and interpretation”.
In summary, Justice Fothergill determined that the “Minister’s interpretation of s 5(1) of the PM(NOC) Regulations as applying only to a version of a drug that has a specific drug identification number [DIN] and that is marketed in Canada was reasonable, particularly considering the statutory objective of providing a patent enforcement mechanism only in relation to products that are in fact available to Canadians”.
Authors
Expertise
Insights
-
Intellectual Property
Bacardí Toasts to a Successful Appeal
There has been a new development in a long-standing trademark dispute between Bacardí and the Cuban government entity, Cubaexport, over the "Havana Club" name. Bacardí won its appeal at the US… -
Intellectual Property
Warhol: Landmark Copyright Case Settles
The Andy Warhol Foundation for the Visual Arts has reportedly agreed to settle a copyright infringement proceeding with Lynn Goldsmith over a photograph of Prince that Goldsmith claimed Andy Warhol… -
Intellectual Property
Boeing Lawsuit Blasts Off: Virgin Galactic Accused of Stealing Trade Secrets
Boeing and its subsidiary, Aurora Flight Sciences, are reportedly suing Virgin Galactic, a space tourism start-up, for allegedly misappropriating trade secrets and failing to pay $25 million for work… -
Intellectual Property
All Posts Game, Set, Match: Sony PlayStation Victorious in Patent Infringement Lawsuit
In 2017, Genuine Enabling Technology (“GET”) filed a complaint against the Sony Corporation (“Sony”), which included a claim that Sony infringed one of its patents related to a method of communication… -
Intellectual Property
Goodmans Wins Leading IP Law Firm – IP Patents at the Lexology Awards: North America 2024
We are proud to share Goodmans has won Leading IP Law Firm - IP Patents at the Lexology Awards: North America 2024. These awards celebrate outstanding achievements and world class client… -
Intellectual Property
Protecting Heads and the Ideas Inside: Yamaha’s Augmented Reality Helmet
A Yamaha patent application has been published for a new design of an augmented reality (AR) motorcycle helmet. The design introduces transparent lenses, which aim to combine the power of the AR…